查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1451343

2024-2032 年痤瘡藥物市場報告（依痤瘡類型、藥物類別、藥物類型、給藥途徑和地區）

Acne Drugs Market Report by Acne Type, Drug Class, Drug Type, Route of Administration, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2023年全球痤瘡藥物市場規模達到69億美元。展望未來， IMARC Group預計到2032年市場規模將達到109億美元，2024-2032年複合年成長率（CAGR）為5.2%。青少年和成人痤瘡盛行率的增加、人們對護膚的認知和重視不斷增強、醫藥研發的進步帶來了創新療法、新興經濟體可支配收入的增加以及社交媒體對護膚趨勢的影響，這些都促進了市場的成長。

痤瘡藥物是一種專門用於控制和緩解痤瘡症狀的藥物或非處方 (OTC) 產品，痤瘡是一種常見的皮膚病，其特徵是存在丘疹、黑頭、白頭和發炎。這些藥物在護膚行業中至關重要，並且是尋求緩解痤瘡相關問題的個人的主要資源。痤瘡藥物的優點包括能夠減少發炎、疏通毛孔、控制油脂產生，並最終促進皮膚更潔淨、更健康。它們為尋求管理和改善皮膚狀況的個人提供了寶貴的資源，強調了這些治療在皮膚病學和皮膚護理領域的重要性。治療痤瘡的藥物有多種類型，主要分為外用治療和口服治療。外用藥物通常以乳膏、凝膠或乳液的形式出現，直接塗在受影響的皮膚上。另一方面，口服藥物被攝取並在體內發揮作用來對抗痤瘡。

全球痤瘡藥物市場受到全球青少年和成人痤瘡盛行率日益上升的影響。人們對護膚和外觀的認知和重視程度不斷提高，進一步支持了這一點。此外，藥物研發的進步導致創新和更有效的痤瘡藥物配方的推出，有助於市場擴張。此外，新興經濟體可支配收入水準的上升使消費者有能力投資痤瘡治療產品，這反過來又促進了市場成長。此外，社群媒體和名人對護膚品代言的影響正在刺激市場成長。除此之外，不斷擴大的化妝品行業和個人化護膚解決方案的趨勢正在加速市場成長。

痤瘡藥物市場趨勢/促進因素：

痤瘡患病率增加

由於全球青少年和成人痤瘡盛行率不斷上升，全球痤瘡藥物市場正在大幅成長。痤瘡是一種常見的皮膚病，其特徵是形成丘疹、黑頭和白頭，影響全球數百萬人。痤瘡病例激增主要歸因於多種因素，包括青春期荷爾蒙變化、壓力水平增加以及不良飲食和護膚習慣等生活方式因素。因此，對有效的痤瘡治療方案的需求不斷成長，以解決這一廣泛的問題。這個促進因素凸顯了製藥公司迫切需要開發和提供創新、可靠且易於使用的痤瘡藥物，以滿足不同患者群體的需求，從而推動全球痤瘡藥物市場的成長。

人們對護膚的認知與重視程度不斷提高

全球痤瘡藥物市場的另一個關鍵驅動力是人們對護膚和個人外表的認知和重視不斷增強。在當今注重形象的社會中，人們越來越傾向於投資護膚產品和治療，以獲得潔淨無瑕的肌膚。這種意識的提高是由社群媒體的影響所推動的，在社群媒體上，無瑕的皮膚經常被描繪成理想的標準。因此，消費者更加主動地尋求管理和治療痤瘡的解決方案。市場受益於對痤瘡藥物和治療的需求增加，因為個人願意探索各種產品和療法來增強皮膚的健康和外觀，從而促進市場的強勁成長。

藥物研究與開發的進展

全球痤瘡藥物市場受到藥物研發（R＆D）不斷進步的顯著推動。製藥公司正在積極開發創新且更有效的痤瘡治療配方。這些進步涵蓋各個方面，包括新型活性成分的發現、改進的藥物傳輸系統以及針對痤瘡病理生理學多個方面的聯合療法的開發。這些創新導致更安全、更有效、見效更快的痤瘡藥物的推出，最終滿足患者不斷變化的需求。此外，副作用較少的外用和口服藥物的開發證明了研發工作所取得的進展。因此，這些創新透過為醫療保健專業人員和患者提供有效管理痤瘡的優質治療選擇來推動市場成長。

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球痤瘡藥物市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按痤瘡類型

  • 粉刺性
    • 市場走向
    • 市場預測
  • 發炎
    • 市場走向
    • 市場預測
  • 囊性
    • 市場走向
    • 市場預測
  • 手術後/傷口
    • 市場走向
    • 市場預測

第 7 章：市場區隔：依藥物類別

  • 類維生素A
    • 市場走向
    • 市場預測
  • 抗生素
    • 市場走向
    • 市場預測
  • 荷爾蒙劑
    • 市場走向
    • 市場預測
  • 複方藥物
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：市場區隔：依藥物類型

  • 非處方藥
    • 市場走向
    • 市場預測
  • 處方藥
    • 市場走向
    • 市場預測

第 9 章：市場區隔：依管理途徑

  • 專題
    • 市場走向
    • 市場預測
  • 口服
    • 市場走向
    • 市場預測
  • 可注射
    • 市場走向
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Allergan Plc
    • Bausch Health Companies Inc.
    • Bayer Aktiengesellschaft
    • Cipher Pharmaceuticals Inc.
    • Galderma Holding SA
    • Johnson & Johnson
    • Pfizer Inc.
    • Reckitt Benckiser Group Plc
    • Skinvisible Pharmaceuticals Inc.
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112024A2359

The global acne drugs market size reached US$ 6.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032. Increasing prevalence of acne among adolescents and adults, growing awareness and emphasis on skincare, advancements in pharmaceutical R&D leading to innovative treatments, rising disposable incomes in emerging economies, and social media influence on skincare trends are facilitating the market growth.

Acne drugs are pharmaceutical or over-the-counter (OTC) products specifically designed to manage and alleviate the symptoms of acne, a common skin condition characterized by the presence of pimples, blackheads, whiteheads, and inflammation. These medications are pivotal in the skincare industry and serve as a primary resource for individuals seeking relief from acne-related concerns. Advantages of acne drugs include their ability to reduce inflammation, unclog pores, control oil production, and ultimately promote clearer, healthier skin. They offer a valuable resource for individuals seeking to manage and improve their skin condition, underlining the significance of these treatments in the realm of dermatology and skincare. There are various types of acne drugs available, primarily categorized into topical and oral treatments. Topical medications typically come in the form of creams, gels, or lotions and are applied directly to the affected skin. On the other hand, oral medications are ingested and work internally to combat acne.

The global acne drugs market is influenced by the increasing prevalence of acne among adolescents and adults worldwide. This is further supported by the growing awareness and emphasis on skincare and appearance. Moreover, advancements in pharmaceutical research and development, leading to the introduction of innovative and more efficient acne drug formulations, contribute to market expansion. Additionally, the rise in disposable income levels in emerging economies empowers consumers to invest in acne treatment products, which, in turn, is augmenting the market growth. Furthermore, the influence of social media and celebrity endorsements of skincare products is stimulating the market growth. Apart from this, the expanding cosmetic industry and the trend towards personalized skincare solutions are accelerating the market growth.

Acne Drugs Market Trends/Drivers:

Increasing prevalence of acne

The global acne drugs market is witnessing a substantial surge due to the escalating prevalence of acne among adolescents and adults worldwide. Acne, a common skin condition characterized by the formation of pimples, blackheads, and whiteheads, affects millions of individuals across the globe. This surge in acne cases is primarily attributed to various factors, including hormonal changes during puberty, increased stress levels, and lifestyle factors such as poor diet and inadequate skincare routines. As a result, there is a growing demand for effective acne treatment options to address this widespread concern. This driver underscores the urgent need for pharmaceutical companies to develop and provide innovative, reliable, and accessible acne medications that cater to diverse patient populations, thereby fueling the growth of the global acne drugs market.

Growing awareness and emphasis on skincare

Another critical driver of the global acne drugs market is the growing awareness and emphasis on skincare and personal appearance. In today's image-conscious society, individuals are increasingly inclined to invest in skincare products and treatments to achieve clear and blemish-free skin. This heightened awareness is driven by the influence of social media, where flawless skin is often portrayed as an ideal standard. As a result, consumers are more proactive in seeking solutions to manage and treat acne. The market benefits from this heightened demand for acne drugs and treatments, as individuals are willing to explore a wide range of products and therapies to enhance their skin's health and appearance, thus contributing to the market's robust growth.

Advancements in pharmaceutical research and development

The global acne drugs market is significantly propelled by continuous advancements in pharmaceutical research and development (R&D). Pharmaceutical companies are actively engaged in developing innovative and more efficient formulations for acne treatment. These advancements encompass various aspects, including the discovery of novel active ingredients, improved drug delivery systems, and the development of combination therapies that target multiple aspects of acne's pathophysiology. Such innovations result in the introduction of safer, more effective, and faster-acting acne drugs, ultimately meeting the evolving needs of patients. Furthermore, the development of topical and oral medications with fewer side effects is a testament to the progress made in R&D efforts. Consequently, these innovations drive market growth by providing healthcare professionals and patients with superior treatment options for managing acne effectively.

Acne Drugs Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global acne drugs market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on acne type, drug class, drug type, and route of administration.

Breakup by Acne Type:

Comedonal

Inflammatory

Cystic

Postsurgical/Wound

A detailed breakup and analysis of the market based on the acne type has been provided in the report. This includes comedonal, inflammatory, cystic, and postsurgical/wound.

For the comedonal segment, key drivers include the surging prevalence of non-inflammatory acne cases, rising awareness among individuals regarding mild acne treatment, increased accessibility to over-the-counter remedies, pharmaceutical companies' focus on targeted solutions, and the pursuit of clear, blemish-free skin. In the Inflammatory segment, drivers encompass the demand for potent anti-inflammatory agents, growing cases of moderate to severe acne, continuous research efforts to develop effective solutions, dermatologist recommendations, and the influence of social media on seeking medical-grade treatments. Cystic acne's drivers revolve around its severity, leading to a higher demand for prescription-based medications, the need for specialized treatments, increased patient awareness, emerging innovative therapies, and the aspiration to prevent scarring. Postsurgical/wound acne treatment segment is driven by factors such as the need for post-procedure skincare, the rise in cosmetic surgeries, scar prevention, dermatologist prescriptions, and the emphasis on post-surgical recovery and aesthetics.

Breakup by Drug Class:

Retinoids

Antibiotics

Hormonal Agents

Combination Drugs

Others

Retinoids dominate the market

The report has provided a detailed breakup and analysis of the market based on the drug class. This includes retinoids, antibiotics, hormonal agents, combination drugs, and others. According to the report, retinoids represented the largest segment.

The retinoids segment within the global acne drugs market is driven by the surging awareness regarding the advantages of retinoids in acne treatment. Their efficacy lies in their ability to regulate skin cell turnover, prevent the formation of comedones (blackheads and whiteheads), and reduce inflammation. This proven track record makes retinoids a go-to choice for both healthcare professionals and individuals seeking reliable acne solutions. Furthermore, retinoids have garnered widespread dermatologist endorsement, underlining their credibility and medical backing. Dermatologists often prescribe retinoids, either in topical or oral form, for various acne types, especially for moderate to severe cases. Another driving factor is the continuous innovation in retinoid formulations. Pharmaceutical companies are investing in research and development to enhance the tolerability and effectiveness of retinoid-based treatments, reducing side effects commonly associated with them. Moreover, the demand for retinoids extends beyond acne treatment, as they are also recognized for their anti-aging properties, further expanding their market reach. This dual functionality appeals to a broader consumer base.

Breakup by Drug Type:

OTC Drugs

Prescription Drugs

A detailed breakup and analysis of the market based on the drug type has also been provided in the report. This includes OTC drugs and prescription drugs.

Over-the-counter (OTC) drugs segment are witnessing substantial growth, driven by their easy accessibility and the increasing preference for self-care solutions. Consumers appreciate the convenience of obtaining these medications without prescriptions, enabling them to manage mild to moderate acne independently. The growing trend of self-care further bolsters their popularity, with individuals seeking swift remedies for common skin concerns, readily available at pharmacies, supermarkets, and online outlets. On the other hand, the prescription drugs segment thrives on dermatologist recommendations and the severity of acne cases. Dermatologists, recognized authorities in skin conditions, frequently prescribe potent, tailored medications for moderate to severe acne cases. This professional endorsement significantly influences patients' choices, directing them towards prescription drugs. These specialized formulations are designed to address specific skin issues effectively. As a result, the demand for prescription-based solutions remains robust, contributing significantly to the growth of this segment.

Breakup by Route of Administration:

Topical

Oral

Injectable

Topical holds the largest share in the market

A detailed breakup and analysis of the market based on the route of administration has also been provided in the report. This includes topical, oral, and injectable. According to the report, topical represented the largest segment.

The topical segment within the global acne drugs market is driven by the convenience of topical treatments plays a significant role, as these products are easy to apply directly to affected areas, making them a preferred choice for many individuals seeking localized acne management. Moreover, the efficacy and safety of topicals have improved over the years, thanks to continuous advancements in pharmaceutical research and development, leading to formulations with fewer side effects and better outcomes. In line with this, dermatologist recommendations heavily influence the topical segment, as medical professionals often prescribe specific topical medications tailored to a patient's unique skin condition. Furthermore, the broad range of topicals available, including creams, gels, and lotions, provides options that cater to various skin types and preferences. Additionally, the accessibility of over-the-counter (OTC) topical acne treatments contributes to the segment's growth, enabling individuals to address mild to moderate acne issues independently. Apart from this, the increasing awareness of skincare and the desire for clear, blemish-free skin further propel the demand for topical acne treatments, emphasizing their integral role in the global market.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest acne drugs market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's acne drugs market is influenced by several key factors, including the region's high prevalence of acne among adolescents and adults, underlining the demand for effective treatments. Furthermore, advanced healthcare infrastructure and accessibility to dermatologists and medical professionals enhance diagnosis and prescription of acne medications. In line with this, a robust consumer inclination towards skincare and appearance maintenance contributes to market growth. This is further supported by the prevalence of a well-established cosmetic and pharmaceutical industry, which fosters innovation and product development in the acne drugs sector. Moreover, awareness campaigns and skincare education initiatives play a crucial role in creating a proactive approach toward acne management. Additionally, regulatory support and stringent quality standards in North America ensure the safety and efficacy of acne drugs, further bolstering consumer trust in the market.

Competitive Landscape:

The competitive landscape of the global acne drugs market is characterized by a diverse array of pharmaceutical and healthcare companies striving to offer innovative and effective solutions for acne treatment. While specific players are not mentioned here due to the user's request, it's important to note that the market fosters competition through research and development, strategic collaborations, and product diversification. Companies within this space are continually investing in R&D to formulate new medications and therapies that target various types of acne, ranging from mild to severe cases. Partnerships with dermatologists and skincare experts help in endorsing their products, adding credibility and market reach. Furthermore, marketing strategies, including digital marketing and social media, play a pivotal role in promoting their products and educating consumers about effective acne management. The competitive landscape emphasizes the importance of quality, safety, and innovation in addressing the diverse needs of individuals seeking acne treatments, ultimately benefiting consumers with a wider range of options and improved solutions.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Allergan Plc

Bausch Health Companies Inc.

Bayer Aktiengesellschaft

Cipher Pharmaceuticals Inc.

Galderma Holding SA

Johnson & Johnson

Pfizer Inc.

Reckitt Benckiser Group Plc

Skinvisible Pharmaceuticals Inc.

Sun Pharmaceutical Industries Limited

Teva Pharmaceutical Industries Ltd.

Recent Developments:

In May 2023, Bausch Health Companies Inc. announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for investigational IDP-126 (clindamycin 1.2%/adapalene 0.15%/benzoyl peroxide 3.1%) Gel with a Prescription Drug User Fee Act (PDUFA).

In June 2023, Sun Pharmaceutical Industries Ltd, received approval of Health Canada, the country's health regulator, for its WINLEVI cream, used in treating certain skin ailments.

In September 2023, Marksans Pharma completed the acquisition of Teva Pharmaceuticals in India to continue providing an uninterrupted supply of Teva's important medicines to customers and patients.

Key Questions Answered in This Report

  • 1. How big is the global acne drugs market?
  • 2. What is the expected growth rate of the global acne drugs market during 2024-2032?
  • 3. What are the key factors driving the global acne drugs market?
  • 4. What has been the impact of COVID-19 on the global acne drugs market?
  • 5. What is the breakup of the global acne drugs market based on the drug class?
  • 6. What is the breakup of the global acne drugs market based on the route of administration?
  • 7. What are the key regions in the global acne drugs market?
  • 8. Who are the key players/companies in the global acne drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Acne Drugs Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Acne Type

  • 6.1 Comedonal
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Inflammatory
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Cystic
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Postsurgical/Wound
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Retinoids
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Antibiotics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hormonal Agents
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Combination Drugs
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Drug Type

  • 8.1 OTC Drugs
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Prescription Drugs
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Route of Administration

  • 9.1 Topical
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Oral
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Injectable
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Allergan Plc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Cipher Pharmaceuticals Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Galderma Holding SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Reckitt Benckiser Group Plc
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Skinvisible Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sun Pharmaceutical Industries Limited
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Teva Pharmaceutical Industries Ltd.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Acne Drugs Market: Major Drivers and Challenges
  • Figure 2: Global: Acne Drugs Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Acne Drugs Market: Breakup by Acne Type (in %), 2023
  • Figure 4: Global: Acne Drugs Market: Breakup by Drug Class (in %), 2023
  • Figure 5: Global: Acne Drugs Market: Breakup by Drug Type (in %), 2023
  • Figure 6: Global: Acne Drugs Market: Breakup by Route of Administration (in %), 2023
  • Figure 7: Global: Acne Drugs Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Acne Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Acne Drugs (Comedonal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Acne Drugs (Comedonal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Acne Drugs (Inflammatory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Acne Drugs (Inflammatory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Acne Drugs (Cystic) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Acne Drugs (Cystic) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Acne Drugs (Postsurgical/Wound) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Acne Drugs (Postsurgical/Wound) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Acne Drugs (Retinoids) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Acne Drugs (Retinoids) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Acne Drugs (Antibiotics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Acne Drugs (Antibiotics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Acne Drugs (Hormonal Agents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Acne Drugs (Hormonal Agents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Acne Drugs (Combination Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Acne Drugs (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Acne Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Acne Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Acne Drugs (OTC Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Acne Drugs (OTC Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Acne Drugs (Prescription Drugs) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Acne Drugs (Prescription Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Acne Drugs (Topical) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Acne Drugs (Topical) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Acne Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Acne Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Acne Drugs (Injectable) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Acne Drugs (Injectable) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia Pacific: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia Pacific: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Acne Drugs Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Acne Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Acne Drugs Industry: SWOT Analysis
  • Figure 86: Global: Acne Drugs Industry: Value Chain Analysis
  • Figure 87: Global: Acne Drugs Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Acne Drugs Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Acne Drugs Market Forecast: Breakup by Acne Type (in Million US$), 2024-2032
  • Table 3: Global: Acne Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
  • Table 4: Global: Acne Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
  • Table 5: Global: Acne Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
  • Table 6: Global: Acne Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Acne Drugs Market Structure
  • Table 8: Global: Acne Drugs Market: Key Players